TLRY Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$7.84median target· current $4.54 (+72.7%)10 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 1000.00
EPS (TTM)$-1.090.0% YoY
Profit margin-13.3%HEALTHCARE
Market cap$618.4MSmall cap
Valuation
- Forward P/E
- 1000.00
- PEG ratio
- —
- P/B
- 0.38
- P/S (TTM)
- 0.68
- EV/EBITDA
- 83.31
Profitability & growth
- ROE (TTM)
- -6.8%
- Operating margin
- -52.7%
- Revenue growth YoY
- -7.8%
- Dividend yield
- —
- Beta
- 1.90
Last earnings
Jul 28, 2026 · Estimate $-0.02 · Reported $-0.43
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Tilray Inc
Company profileTilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
Classification
- Sector
- Healthcare
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 265 TALBOT STREET WEST, LEAMINGTON, ON
- Fiscal year end
- May
- Latest quarter
- May 31, 2026
Market cap$618.4M
Shares outstanding$136.2M
52W high$23.20
52W low$3.67
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent